Target intelligence / Profile preview

Gamma-aminobutyric acid type A receptor alpha1-beta-delta subtype (GABA_A receptor α1βδ)

Target
GABA_A receptor α1βδ
Molecular classification
Ion channel, Receptor, Ligand-gated ion channel, Cys-loop receptor family
01

Overview

The Gamma-aminobutyric acid type A (GABA_A) receptor α1βδ subtype is a specific heteropentameric ligand-gated ion channel typically composed of two α1 subunits, two β subunits (such as β2 or β3), and one δ subunit (nih.gov, 2025). Unlike the more prevalent synaptic αβγ isoforms that mediate rapid phasic inhibition, α1βδ receptors are primarily localized to extrasynaptic and perisynaptic membranes, where they mediate a persistent "tonic" inhibitory current that regulates the baseline excitability of neurons (nih.gov, 2025; wikipedia.org, 2024). This subtype is characterized by a high affinity for GABA and slow desensitization, allowing it to respond to low ambient concentrations of the neurotransmitter in the extracellular space (nih.gov, 2025). Pharmacologically, α1βδ receptors are distinguished by their insensitivity to classical benzodiazepines and their high sensitivity to neurosteroids (e.g., allopregnanolone, ganaxolone), ethanol, and the selective agonist gaboxadol (nih.gov, 2025). Dysregulation of α1βδ-mediated tonic inhibition is implicated in various neurological and psychiatric conditions, including epilepsy, anxiety, and postpartum depression (nih.gov, 2025). Consequently, it serves as a significant therapeutic target for the development of novel anticonvulsants, sedatives, and antidepressants aimed at restoring inhibitory balance in the central nervous system.

Other names
alpha1-beta-delta GABA-A receptorGABAA receptor alpha1-beta-deltaExtrasynaptic alpha1-containing GABA-A receptordelta-containing alpha1 GABA-A receptorGABRA1-GABRB-GABRD complex
02

Mechanism of action

Positive allosteric modulation and direct agonism of the chloride ion channel

03

Biological functions

Tonic inhibitionChloride transportRegulation of neuronal excitabilitySignal transduction
04

Disease associations

EpilepsyInsomniaAnxietyPostpartum depressionSchizophreniaNeurodevelopmental disorders
05

Safety considerations

SedationAtaxiaMotor impairmentPotential for abuseRespiratory depression at high doses
06

Interacting drugs

Gaboxadol

8 more in the full profile.

07

Biomarkers

GABRA1 expression levelsGABRD expression levelsTonic inhibitory current density

Beyond the preview

Go deeper on Gamma-aminobutyric acid type A receptor alpha1-beta-delta subtype (GABA_A receptor α1βδ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha1-beta-delta subtype (GABA_A receptor α1βδ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call